ABT vs TTC · P/E 25, rev $44.33B vs P/E 26, rev $3.69B
Abbott Laboratories (ABT) versus Toro Co (TTC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Toro Co (TTC) is a tools & accessories company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TTC revenue for 2026-07-31 was $3.69B. Net income was $290.3M. Revenue was up 49.8% from 2026-05-01 to 2026-07-31. TTC currently screens at market cap $8.65B and trailing P/E 26.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TTC currently screens at market cap $8.65B and trailing P/E 26.2.
Not investment advice. Open the ABT and TTC stock pages for the full models.
Not investment advice.